A novel SPTB mutation causes hereditary spherocytosis via loss-of-function of β-spectrin Shan LiPing GuoJuan Li Original Article 31 January 2022 Pages: 731 - 738
HLA-G-ILT2 interaction contributes to suppression of bone marrow B cell proliferation in acquired aplastic anemia Yuan-xin SunQi FengJun Peng Original Article 18 January 2022 Pages: 739 - 748
Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomy Giovanni CaocciFabio EfficaceGiorgio La Nasa Original Article 31 January 2022 Pages: 749 - 754
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL—a matched cohort analysis Irit AviviChava PerryRon Ram Original Article 27 January 2022 Pages: 755 - 762
Efficacy and safety comparison between R-CHOP and modified NHL-BFM-90 regimens in children and adolescents with diffuse large B-cell lymphoma Jinqiu GuanFeifei SunYizhuo Zhang Original Article 08 January 2022 Pages: 763 - 771
Identification of CD105 (endoglin) as novel risk marker in CLL Sarah M. GreinerMelanie MärklinJoseph Kauer Original Article Open access 19 January 2022 Pages: 773 - 780
90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years Kathrin RiegerRosaria De FilippiChristian W. Scholz Original Article Open access 12 February 2022 Pages: 781 - 788
Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL) A. JanikovaJ. MichalkaM. Trneny Original Article 21 January 2022 Pages: 789 - 798
Prognostic implication of CTLA-4, PD-1, and PD-L1 expression in aggressive adult T-cell leukemia–lymphoma Akio OnishiShigeo FujiTakahiro Fukuda Original Article 15 January 2022 Pages: 799 - 810
Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells Elisabeth K. M. MackSören HartmannJörg Hoffmann Original Article Open access 01 February 2022 Pages: 811 - 824
Revisiting the impact of immunoglobulin isotypes in multiple myeloma Susan BalSmith GiriLuciano J. Costa Original Article 09 February 2022 Pages: 825 - 829
Benefit of high-dose idarubicin as induction therapy in acute myeloid leukemia: a prospective phase 2 study Yue-ying MaoHua-cong CaiJian Li Original Article 17 January 2022 Pages: 831 - 836
Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations Sayantanee DuttaJennifer MoritzHeinz Sill Original Article Open access 26 January 2022 Pages: 837 - 846
3′CBFB deletion in CBFB-rearranged acute myeloid leukemia retains morphological features associated with inv(16), but patients have higher risk of relapse and may require stem cell transplant Guilin TangYing ZouZhenya Tang Original Article 20 February 2022 Pages: 847 - 854
Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study Federica MartellaMarco CerranoEloise Beggiato Original Article 07 February 2022 Pages: 855 - 867
A fludarabine and melphalan reduced-intensity conditioning regimen for HSCT in fifteen chronic granulomatous disease patients and a literature review Mohammad VaeziMaryam SouriArdeshir Ghavamzadeh Original Article 08 January 2022 Pages: 869 - 880
CD20/CD79a/PAX5/CD3-negative post-transplant lymphoma with aberrant actin and desmin co-expression—a potential differential diagnostic pitfall between PTLD and PTSMT Jan-Theile SuhrenJerome SchluéKais Hussein Letter to the Editor Open access 18 February 2022 Pages: 881 - 883
Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination Kei SaitoSatoshi IchikawaTohru Izumi Letter to the Editor 01 October 2021 Pages: 885 - 887
Falsely elevated serum vitamin B12 levels in a case of pernicious anemia Edwin W. S. ThongShaun S. TanWei-Ying Jen Letter to the Editor 10 September 2021 Pages: 889 - 892
Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosis Damien Luque PazLaurane CottinCorentin Orvain Letter to the Editor 05 October 2021 Pages: 893 - 896
Detection of pulse rate elevation by Apple Watch in a patient with bronchiolitis obliterans syndrome after allogeneic stem cell transplantation Toshiki MushinoAkinori NishikawaTakashi Sonoki Letter to the Editor 31 July 2021 Pages: 897 - 899
T-cell receptor-silent peripheral T-cell lymphoma complicated with hemophagocytic lymphohystiocytosis Koya OnoYasushi OnishiHideo Harigae Letter to the Editor 30 August 2021 Pages: 901 - 903
Need for integrating early palliative care with standard hematology care long before the allogeneic hemopoietic stem cells transplantation Leonardo PotenzaEleonora BorelliElena Bandieri Letter to the Editor 18 August 2021 Pages: 905 - 906
Previously unreported WRAP53 gene variants in a patient with dyskeratosis congenita Eugene BrailovskiHubert TsuiRena Buckstein Letter to the Editor 02 October 2021 Pages: 907 - 909
Indolent T cell lymphoma involving the central nervous system and successfully treated by bendamustine Min HuiMiao Chen Letter to the Editor 06 September 2021 Pages: 911 - 913
Coombs’ test positive autoimmune hemolytic anemia accompanied by myelodysplastic syndrome that became Coombs’ test negative after azacitidine administration Shinya YamadaSayaka KajikawaHirokazu Okumura Letter to the Editor 27 August 2021 Pages: 915 - 917
The incidental discovery of a constitutional trisomy 21 mosaicism in an adult female with myelodysplastic/myeloproliferative neoplasm Samantha O’Hagan HendersonAnita GlaserInken Hilgendorf Letter to the Editor Open access 01 September 2021 Pages: 919 - 920
A rare de novo pure erythroid leukemia with JAK2 R683S mutation Rebecca Z XuAly KarsanBrian R. Berry Letter to the Editor 04 September 2021 Pages: 921 - 922
Mortality by COVID-19 in adults with acute myeloid leukemia: a survey with hematologists in Brazil Evandro M. FagundesNaira N. NetoOlivia G. Fagundes Letter to the Editor 17 September 2021 Pages: 923 - 925
Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccination Marcel KemperChristoph BerssenbrüggeRolf Michael Mesters Letter to the Editor Open access 10 August 2021 Pages: 927 - 928
Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis Giovanni CaocciOlga MulasGiorgio La Nasa Letter to the Editor 24 July 2021 Pages: 929 - 931
Association of blood type A with increased risk of severe COVID-19 in healthcare workers Niraj N. MahajanRahul K. GajbhiyePradip D. Lokhande Letter to the Editor 22 August 2021 Pages: 933 - 934